Biochemical Remission

Biochemical Remission is a clinical outcome criterion in autoimmune liver disease treatment characterized by the normalization of elevated liver enzymes, particularly alanine aminotransferase and aspartate aminotransferase, in the absence of symptoms and without histological worsening, thereby distinguishing it from complete or histological remission which require additional pathological or immunological normalization.

1.4K

Publications

76.7K

Citations

8.1K

Authors

2.1K

Institutions

Publications per year

2017–2026

308

Authors

8.1K

  1. AW
    Ansgar W. Lohse

    Universität Hamburg, Germany

    8 publications · 612 citations

    8

    h-index

  2. JP
    Joost P.H. Drenth

    Radboud University Nijmegen, Netherlands

    8 publications · 557 citations

    8

    h-index

  3. MP
    Marieke Pierik

    Maastricht University, Netherlands

    8 publications · 434 citations

    8

    h-index

  4. UB
    Ulrich Beuers

    University of Amsterdam, Netherlands

    7 publications · 576 citations

    7

    h-index

  5. VB
    Vince Biemans

    Radboud University Medical Center, Netherlands

    7 publications · 402 citations

    7

    h-index

1–5 of 8.1K

Venues

  1. PubMed

    Repository · 133 publications · 4.8K citations

    36

    h-index

  2. The Journal of Clinical Endocrinology & Metabolism

    JCEM · 42 publications · 3.2K citations

    31

    h-index

  3. Clinical Endocrinology

    31 publications · 1.9K citations

    24

    h-index

  4. Alimentary Pharmacology & Therapeutics

    28 publications · 1.6K citations

    24

    h-index

  5. European Journal of Endocrinology

    EJE · 32 publications · 1.4K citations

    23

    h-index

1–5